Cigarette Company Paid for Lung Cancer Study

In October 2006, Dr. Claudia Henschke of Weill Cornell Medical College jolted the cancer world with a study saying that 80 percent of lung cancer deaths could be prevented through widespread use of CT scans.

Small print at the end of the study, published in The New England Journal of Medicine, noted that it had been financed in part by a little-known charity called the Foundation for Lung Cancer: Early Detection, Prevention & Treatment. A review of tax records by The New York Times shows that the foundation was underwritten almost entirely by $3.6 million in grants from the parent company of the Liggett Group, maker of Liggett Select, Eve, Grand Prix, Quest and Pyramid cigarette brands.

The foundation got four grants from the Vector Group, Liggett’s parent, from 2000 to 2003.

Read full story

More on This

Women More Likely to Develop Lung Cancer From Smoking

Former Smokers: What's Your Risk for Lung Cancer?

Number One Cancer Killer of Women Is Lung Cancer: Are You At Risk?

The Grim Facts about Smoking and Lung Cancer

Tags:

• Lung Cancer